Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mefloquine in Progressive Multifocal Leukoencephalopathy
NCT00746941Phase 2Terminated
- Sponsor
- Biogen
- Start
- Jan 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of mefloquine in progressive multifocal leukoencephalopathy (PML), sponsored by Biogen. Started Jan 2009; status: terminated.
02
Drugs
mefloquine
03
Conditions
progressive multifocal leukoencephalopathy (PML)
Beyond the preview
Go deeper on NCT00746941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00746941.